Cargando…

New additions to the History of Headache Section

Detalles Bibliográficos
Autor principal:	Zanchin, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2004
Materias:	History of Headache Section
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749061/ http://dx.doi.org/10.1007/s10194-004-0137-y

Ejemplares similares

Headache among the educated in the century of enlightment
por: Zanchin, Giorgio, et al.
Publicado: (2004)

Introduction to the History of Headache Section
Publicado: (2004)

Sources
por: Zanchin, Giorgio
Publicado: (2004)

The nervous system in colours: the tabulae pictae of G.F. d’Acquapendente (ca. 1533–1619)
por: Zanchin, G., et al.
Publicado: (2006)

When cluster headache was called histaminic cephalalgia (Horton’s headache)
por: Fanciullacci, M.
Publicado: (2006)

Concepts leading to the definition of the term cervicogenic headache: a historical overview
por: Antonaci, F., et al.
Publicado: (2005)

The History of the Migraine Trust
por: Rose, F. C.
Publicado: (2006)

Section editor note
por: Zanchin, Giorgio
Publicado: (2006)

Headaches and obesity
por: Fortini, Ida, et al.
Publicado: (2022)

Chronic paroxysmal hemicrania, hemicrania continua and SUNCT: the fate of the three first described cases
por: Sjaastad, Ottar
Publicado: (2006)

Multinational descriptive analysis of the real‐world burden of headache using the Migraine Buddy application
por: Goadsby, Peter J., et al.
Publicado: (2021)

Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial
por: Pijpers, Judith A., et al.
Publicado: (2022)

Headache as an acute and post‐COVID‐19 symptom in COVID‐19 survivors: A meta‐analysis of the current literature
por: Fernández‐de‐las‐Peñas, César, et al.
Publicado: (2021)

Weight variations in the prophylactic therapy of primary headaches: 6–month follow–up
por: Maggioni, F., et al.
Publicado: (2005)

Headache advocacy
por: Grisold, Wolfgang, et al.
Publicado: (2023)

Acute Migraine Therapy: New Drugs and New Approaches
por: Monteith, Teshamae S., et al.
Publicado: (2010)

Blunt Head Trauma and Headache
por: Chelse, Ana B., et al.
Publicado: (2015)

Medication–overuse headache: pathophysiological insights
por: Calabresi, P., et al.
Publicado: (2005)

Neurophysiological approach to central pain modulation in primary headaches
por: Rossi, P., et al.
Publicado: (2005)

Treatment of Headache in the Elderly
por: Hershey, Linda A., et al.
Publicado: (2012)

Chronic daily headache in a paediatric headache centre
por: Scalas, C., et al.
Publicado: (2005)

Noninvasive vagus nerve stimulation and morphine transiently inhibit trigeminal pain signaling in a chronic headache model
por: Cornelison, Lauren E., et al.
Publicado: (2020)

Cold extremities in migraine: a marker for vascular dysfunction in women
por: Linstra, K. M., et al.
Publicado: (2020)

Chronic migraine: Genetics or environment?
por: Chalmer, Mona Ameri, et al.
Publicado: (2021)

Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial
por: Ashina, Messoud, et al.
Publicado: (2021)

Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
por: Simioni, Caio Vinicius de Meira Grava
Publicado: (2022)

Update on Idiopathic Intracranial Hypertension Management
por: Souza, Marcio Nattan Portes, et al.
Publicado: (2022)

Vestibular migraine
por: Silva, Viviane Passarelli Ramin, et al.
Publicado: (2022)

It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine
por: Kubota, Gabriel Taricani
Publicado: (2022)

Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real‐world evidence
por: Khalil, Modar, et al.
Publicado: (2022)

Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
por: de Vries Lentsch, Simone, et al.
Publicado: (2021)

First‐line steroid treatment for spontaneous intracranial hypotension
por: Tonello, Simone, et al.
Publicado: (2022)

Clinic and genetic predictors in response to erenumab
por: Zecca, Chiara, et al.
Publicado: (2022)

Functional connectivity changes in complex migraine aura: beyond the visual network
por: Silvestro, Marcello, et al.
Publicado: (2021)

Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT study
por: Vernieri, Fabrizio, et al.
Publicado: (2022)

Attachment styles and headache
por: Savi, L., et al.
Publicado: (2005)

Headache and botulinum toxin
por: Porta, M., et al.
Publicado: (2005)

Headache and mood disorders
por: De Filippis, S., et al.
Publicado: (2005)

Severe acute respiratory syndrome coronavirus 2 infection altered the factors associated with headache: evidence from a multicenter community-based case–control study
por: Ali, Mohammad
Publicado: (2022)

Peripheral Neuromodulation and Headaches: History, Clinical Approach, and Considerations on Underlying Mechanisms
por: Reed, Ken L.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sit9fi7t45n2v8pnqr2g60p72l